CXCL8 and synovial sarcoma: A relevant result was also obtained for IL-8 levels, which were highly increased not only between HCs and patients but also between patients with SS and the group with a more advanced stage of the disease, PMF, which means that this cytokine, along with others, could be a good candidate marker to discriminate between disease stages.